Politiparty
Politiparty

118th Congress Health

H.R. 1117: Advancing Safe Medications for Moms and Babies Act of 2023

Introduced

  1. Introduced (completed)Feb 21, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Feb 21, 2023

This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research.

For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research.

The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance of including pregnant and lactating women in clinical research.

Read the full summary

The National Institutes of Health must also prioritize certain research projects on new and existing medications for pregnant and lactating women based on need, feasibility, and the potential impact of the research.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

30

Bipartisan support.

Who scored on this bill

12 points earned
  1. 1Kathy Castor D-FL SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone3 events+12
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Kathy Castor

History

  1. Feb 21, 2023Introduced in the House by Kathy Castor.
Show the full action history (3 actions)
  1. Mar 3, 2023Referred to the Subcommittee on Health.
  2. Feb 21, 2023Introduced in House
  3. Feb 21, 2023Referred to the House Committee on Energy and Commerce.